Postoperative Blood Loss Clinical Trial
Official title:
Efficacy of Modified Robert Jones Bandages on Reducing Invisible Blood Loss After Total Knee Arthroplasty: A Randomized Controlled Trial
Total knee arthroplasty (TKA) is one of the most successful procedures in orthopaedic
surgery. Nevertheless, significant postoperative blood loss and requirement of blood
transfusion are still problematic. Total blood loss in TKA can be divided into visible and
invisible blood loss. Visible blood loss (VBL) means blood loss from the surgical field and
wound drainage while invisible blood loss (IBL) means residual blood in the knee,
extravasation into the tissues and loss due to haemolysis.
In usual practice, TKA is performed with a bloodless field using a tourniquet. Thus
intraoperative blood loss can be negligible and postoperative drainage is only considered as
VBLvisible. In terms of IBL, Sehat et al. found that TKA carried a substantial IBL. Their
results shown the mean IBL was 765 ml or 49% of the mean total blood loss after TKA.
Therefore, the true total blood loss was underestimated if not takes IBL into account.
Modified Robert Jones bandage (MRJB) is a bulky compressive dressing that often used in
orthopaedic practice. Various techniques of application have been proposed.
From the previous study, MRJB could make and maintain the anterolateral muscle compartment
pressure for at least 24 hours after TKA. Therefore, theoretically, this bandage can cause
the tamponade effect that helps to reduce tissue edema and postoperative bleeding especially
IBL after TKA. However this potential benefit of MRJB is unclear and the use of this bandage
after TKA is still controversy in clinical practice.
In preoperative period, all eligible participants are admitted to the hospital for undergoing
TKA. The detailed protocol, including how to rate visual analog pain score, times to take the
blood for checking hematocrit levels, criteria for blood transfusion, time to measure the
knee and thigh circumferences and plan of ambulation program, is informed again. The routine
preoperative preparation is done. The participant is asked for answering preoperative Oxford
Knee Score questionnaire. Participants' baseline characteristics are also recorded.
During intraoperative period, all participants receive the same anesthetic method (spinal
anesthesia without morphine and peripheral nerve block). Two experienced surgeons (CK and NR)
perform all procedure with the same surgical technique. A 750 mg intravenous tranexamic acid
is administrated before inflating tourniquet and 3 hours after the operation. A tourniquet
pressure of 300 mmHg is used and inflated before skin incision. Pre-incisional local
injection with 10 ml of 1% lidocaine with adrenaline is done. A mini-medial parapatellar
approach is performed. Cemented TKA prostheses (Nexgen LPS-Flex, Zimmer, Warsaw, Indiana) are
implanted in all participants without patellar resurfacing. Periarticular analgesic injection
is done with 20 ml of 0.5% bupivacaine, 20 ml of normal saline, 30 mg of ketorolac and 1 ml
of 1% lidocaine with adrenaline. A number-10-gauge drain is placed intra-articularly and
connected to the Ultravak pressure drainage bottle (Poly Medicure Limited, India). Extensor
mechanisms are repaired and the wound closure is performed in the routine fashion.
At the end of operation, the randomized sequence is opened by a scrub nurse. Then, the
participants are randomly assigned into two groups; Group 1 or MRJB group and Group 2 or
non-compressive dressing (NCD) group. A tourniquet pressure is deflated after the dressing is
applied.
In postoperative period, MRJB is left in place for 24 hours and then changed to NCD. All
participants obtain the three-hour interval drain clamping protocol. After tourniquet
release, the drain is clamped for three hours, released for three hours, re-clamped for three
hours, and then the clamp is run continuously. Mechanical prophylaxis of deep vein thrombosis
by ankle pumping exercise and ambulation on the bed is started as soon as possible. After 24
hours postoperatively, range of motion exercise and out-of-bed ambulation program are
started. Ice packs are placed around the knee for at least 8 hours per day. The drain is
removed at 48 hours after operation.
For operational definition, MRJB is defined as a three-layers of thick cotton wool and
two-layers of elastic bandages. The wool layers are put on firmly and overlapped the previous
one by half at each turn. The elastic layers were pulled snugly with more tension distally
than proximally. Before wrapping in each turn, the elastic bandage was stretched
approximately 2 and 1.5 inches at below and above tibial tuberosity level, respectively. The
whole bandage attains a thickness of about two inches and extends above the ankle joint to
six inches above the knee joint. Before applying this bandage, the sterile gauze pads were
placed over the wound and followed by WebrilTM padding (Covidien, Mansfield, MA, US). While
NCD is made by placing the sterile gauze pads over the wound and covering with the
hypoallergenic self-adhesive, non-woven fabric tape.
All patients receive the same postoperative pain managements, including (1) parecoxib 40 mg
administrated as intravenous bolus every 12 hours for 2 days, then diclofenac 25 mg orally
every 8 hours until discharge, (2) acetaminophen 300 mg with codeine 15 mg orally every 8
hours until discharge, (3) morphine 2 mg intravenously pro re nata (prn) for pain every 2
hours as a rescue drug.
During the first and second 24 hours after surgery, the maximum of visual analog pain scores
at rest and during the ambulation are assessed. The circumferences of knee and thigh at
postoperative 24 and 48 hours are measured by single blinded assessor.
To evaluate of blood loss and determine criteria for blood transfusion, hematocrit levels are
measures at 24 and 48 hours after surgery. The patients will receive a transfusion of one
unit of packed red cells, if their hematocrit levels are less than 30% or if the compromised
clinical criteria (such as hypotension, tachycardia, symptoms of anemia that are relative to
the preoperative medical condition) necessitated blood transfusion. If hematocrit levels are
less than 24%, two units of packed red cells are transfused. The hematocrit levels are
reevaluated at 4 hours after the end of transfusion and blood transfusion is considered again
using the same criteria. Drainage blood loss and amount of blood transfusion are recorded at
24 and 48 hours postoperatively.
At discharge, range of motion is measured again. Clinical venous thromboembolism, peroneal
nerve palsy, infection and wound complications are also assessed.
During follow-up period, range of motion, clinical venous thromboembolism, infection, wound
condition and other complications are reassessed at 2 and 6 weeks after TKA. The functional
outcomes, including Oxford Knee Score and time up and go test, are evaluated at 6 weeks
postoperatively.
Primary outcome in this study is IBL. It means invisible red blood cell (RBC) volume loss
that can be calculated according to the following steps; first, the patient's blood volume
(PBV) is calculated using the Nadler formula.
PBV = k1 x height (m)3 + k2 x weight (kg) + k3 When k1= 0.3669, k2 = 0.03219, k3 = 0.6041 for
men; k1= 0.3561, k2 = 0.03308, k3 = 0.18331 for women Then, multiplying the PBV by the
hematocrit (Hct) will give the total RBC volume. The change in RBC volume can be calculated
from the change in Hct [20]. In this study, total RBC volume loss at postoperative 48 hours
is calculated using the following formula; Total RBC volume loss = PBV x (Preoperative Hct -
Postoperative Hct at 48 hours) At 24 hours after surgery, the volume of drained blood is
measured and then multiplying by the preoperative Hct will give the drainage RBC blood volume
at 24 hours. During 24-48 hours after surgery, the volume of drained blood is measured and
then multiplying by the postoperative Hct at 24 hours will give the drainage RBC blood volume
at 24-48 hours. The summation of drainage RBC blood volume at 24 hours and at 24-48 hours is
total drained RBC volume. If the patient receives blood transfusion, the volume of packed red
cell is also recorded. Finally, invisible blood loss is calculated using the following
formula; Invisible blood loss = Total RBC volume loss - Total drained RBC volume + Transfused
blood volume
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05047133 -
Effect of Early Administration of TXA in Adult Hip Fractures
|
Phase 2/Phase 3 | |
Completed |
NCT02631980 -
HepciFer Study: Hepcidin Overexpression After Hepatectomy : Does Iron Supplementation Make Sense ?
|
Phase 3 | |
Terminated |
NCT00885924 -
Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery
|
Phase 4 | |
Recruiting |
NCT05889494 -
Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients
|
N/A | |
Completed |
NCT02427412 -
Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty
|
Phase 4 | |
Completed |
NCT01475669 -
Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular Surgery
|
Phase 3 | |
Completed |
NCT01622946 -
The Effect of Topical Application of Tranexamic Acid in Total Hip Arthroplasty Through the Direct Anterior Approach
|
Phase 4 | |
Recruiting |
NCT05774717 -
Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis
|
Phase 1 |